Navigation Links
Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation
Date:2/20/2008

PHILADELPHIA, Feb. 20 /PRNewswire/ -- According to Anapol Schwartz (http://www.anapolschwartz.com/) attorney James Ronca (http://www.anapolschwartz.com/attorneys/jim_ronca.shtml), a New England Journal of Medicine study (http://content.nejm.org/cgi/content/short/358/8/771?query=TOC) (to be released in the February 21, 2008, print edition) confirms that Bayer AG's blood-clotting drug Trasylol(R), used in coronary artery bypass graft (CABG) procedures, causes kidney/renal failure and increases mortality risk. While initial findings of the study, commissioned by Bayer, were sent to the drug company and the FDA in 2006, this is the first time the final results have been published in full.

Ronca, who is one of the chairs of the national Trasylol(R) litigation, and represents a dozen families and victims (see Trasylol(R) lawsuit (http://www.anapolschwartz.com/practices/trasylol/) and a recent wrongful death complaint (http://www.anapolschwartz.com/practices/trasylol/thompson-complaint.pdf) filed in Philadelphia), argues this study reinforces inherent problems in the FDA's screening process and opens the floodgates for additional litigation.

"According to published sources, thousands may have died from Trasylol(R), when this could have been prevented. Again, we have another example of the FDA not protecting the public -- and the safety of individuals taking a back seat to company profits," says Ronca, who leads advocacy initiatives to raise awareness about Trasylol's(R) side effects.

Pulled by Bayer from the market in November 2007 in response to FDA concerns, Trasylol(R) is administered by an anesthesiologist during CABG surgery (http://www.anapolschwartz.com/practices/trasylol/thompson-complaint.pdf) to limit bleeding. Affected patients typically experience kidney/renal failure symptoms within 48 hours. Many, however, are unaware they have received the drug, complicating diagnosis.

"These findings should further educate the public about Trasylol's(R) dangers, and open the door for victims, and those who don't realize they are victims, to receive remuneration for their injuries," stresses Ronca, who has served as counsel to victims in product liability cases involving Baycol, LOTRONEX, hormone replacement therapy and breast implants.

Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley is a personal injury firm with law offices in Philadelphia, Reading, Media, and Harrisburg, Pa., as well as Cherry Hill, N.J. (http://www.anapolschwartz.com/contactus.shtml) The firm is a multi-faceted practice with a tradition of excellence in medical malpractice law, pharmaceutical mass tort, toxic tort, class actions, products liability, automobile, securities and wrongful termination litigation. Since its founding in 1977, the firm has grown to over 30 attorneys, and compiled a record of success exceptional among its peers.

Contact: Alexandra Kane-Weiss/Jennifer Wasilisin

215-793-4666

akaneweiss@startoplin.com

jwasilisin@startoplin.com


'/>"/>
SOURCE Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Consumer Driven Healthcare Continues To Make Its Mark on Indianapolis Market
2. St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards
3. Brown Mackie College - Indianapolis Announces New Degree Program in Occupational Therapy
4. Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
5. Tobacco-Free Kids Indiana Action Fund Launches Campaign in Support of Angela Mansfield and Scott Keller for Indianapolis City-County Council
6. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark
7. AHIP Statement on New York Attorney Generals Announcement
8. Pennsylvania Attorney General Approves Vincentian Collaborative System-Marian Manor Integration
9. Former FTC Attorney Christine White Joins Crowell & Morings Health Care and Antitrust Groups
10. Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit
11. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... ... 2017 , ... People who have sensitive teeth are about as common as ... teeth. Sadly, most dental hygiene products in the market contain chemical ingredients that only ... continuing their daily oral care routine to keep their teeth white and healthy is ...
(Date:1/13/2017)... , ... January 13, 2017 , ... Friday, January 13 ... of the game room, increasing the size of the location to 90,000 square feet. ... 8-hole mini golf course that takes customers on an educational tour of the historic ...
(Date:1/13/2017)... ... ... MyGenetx, a molecular laboratory headquartered in middle Tennessee is proud to announce ... LD, will serve on the 2017 TBCC Board. , Kris Wiese was ... year as Vice President. She will oversee the newly elected board of 17. Mary ...
(Date:1/13/2017)... CO (PRWEB) , ... January 13, 2017 , ... As ... a growing alliance of deans of colleges and schools of education across the country ... schools. , In a Declaration of Principles released today, 175 deans sounded the alarm: ...
(Date:1/13/2017)... ... ... Overseer at The House of Yahweh, has published a new article that refutes false accusations ... eternal joy. Yisrayl says he has been accused of being the “prophet of doom,” when ... are nothing new in his world and says it has always been that way for ...
Breaking Medicine News(10 mins):
(Date:1/12/2017)... India , January 12, 2017 ... titled, "IVD Quality Control Products Market by Product Type, by ... Opportunity Analysis and Industry Forecast, 2014 - 2022" The global ... in 2015, and is expected to reach $1,052 million by ... The quality controls products segment dominated the market with fourth-fifths ...
(Date:1/12/2017)... LONDON , Jan. 12, 2017 ... health benefits when consumed, which facilitate digestion, gastrointestinal ... There have been 500 million probiotics ... can realize 15% in some European countries. The ... in the developed countries. In developed countries, ...
(Date:1/12/2017)... , Jan. 12, 2017 "Global ... report analyzes ongoing clinical and non-clinical trends in ... are 3 lung cancer vaccines commercially available in ... trial of 30 lung cancer vaccines in clinical ... parameters associated with the development of the lung ...
Breaking Medicine Technology: